Mimedx (MDXG) Notes Payables (2010 - 2011)
Mimedx (MDXG) posted Notes Payables of $1.3 million for Q4 2011, up 24.44% sequentially from $1.0 million in Q3 2011, and up 221.24% YoY from $403432.0 in Q4 2010.
Mimedx (MDXG) Notes Payables (2010 - 2011) Analysis & Trends
Mimedx has reported Notes Payables for 2 years, with the latest figure at $1.3 million in Q4 2011.
- Quarterly Notes Payables rose 221.24% year-over-year to $1.3 million in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $1.3 million (up 221.24% YoY) and the FY2011 annual result came in at $1.3 million, up 221.24% from the prior year.
- Notes Payables advanced to $1.3 million in Q4 2011 per MDXG's latest filing, from $1.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $1.3 million in Q4 2011 and troughed at $45540.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.04 Mn |
| Jun 30, 2011 | 45,540.00 |
| Dec 31, 2010 | 403,432.00 |